• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,269.40 355.90
( 0.46%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5542386
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
23.09
105811.45
EPS(TTM)
Face Value()
Div & Yield %
56.72
2
1.22
 

IRB Infrastructure Trust wins NHAI road project in Uttar Pradesh
Nov 15,2025
IRB Infrastructure Developers announced that IRB Infrastructure Trust, associate of the company has received a Letter of Award from National Highways Authority of India (NHAI) for the project of involving Tolling, Operation, Maintenance and Transfer of Lucknow-Ayodhya Section of NH-28 (New NH-27) from km 15.400 to km 137.970, Ayodhya-Gorakhpur Section (Km. 136.759 to Km. 252.860) stretch of NH-28 (New NH-27) and Lucknow-Sultanpur Section of NH-731 from Km. 90.370 to km. 217.795 in the state of Uttar Pradesh (TOT-17).

Key highlights of the project:

IRB Infrastructure Developers will be the Project Manager for the Project.

The Trust to pay upfront Bid Concession Fee of Rs. 9,270 crore to NHAI for revenue-linked Concession Period of 20 years.

Trust's asset portfolio will increase by ~20% to ~Rs 65,000 Crore with addition of this project with a long-term revenue & cashflow generation visibility.